ProcuraAxisBeta
Sign inCreate Free Account
Home / Opportunities / Opportunity
PROCUREMENT OPPORTUNITY

Radiopharmaceutical Manufacturing Unit

Guy's and St Thomas' NHS Foundation Trust · Preliminary market engagement notice on Find a Tender

Tender information last checkedLast checked 30 Sept 2026, 07:59.

Opportunity overview

GSTT is seeking to commission an industry partner to design, build and operate a new, purpose-built Good Manufacturing Practice (GMP)-compliant Radiopharmaceutical Manufacturing Unit to support the growing demand for diagnostic (SPECT and PET) and therapeutic radiopharmaceuticals within close proximity of GSTT. It is anticipated a unit of 1,240 m2 within 1.5 miles of Guy’s Hospital will be leased by GSTT and discussions with the landlord are progressing. This initiative aims to establish a hub-and-spoke model, where the new unit will serve as the central hub, and the existing facility at Guy’s Hospital will continue as a spoke. This strategic development will: • Increase manufacturing capacity for routine diagnostics and advanced clinical trials for GSTT and for the wider London market. • Ensure equity of patient access to the latest RP diagnostics and therapeutics. • Support innovative clinical research. • Help future-proof Radiopharmacy services by adapting to evolving market demands. • Develop the Radiopharmacy workforce through education and training programmes to ensure they are equipped with the skills and expertise needed to meet the evolving demands of the industry. This initiative is part of GSTT’s strategic vision to lead in nuclear medicine, enhancing patient access to advanced diagnostics and therapies while driving innovation in radiopharmaceutical production. The new unit will also serve as a centre for education and training, developing the next generation of radiopharmacists and strengthening GSTT’s role as a leader in clinical research and healthcare excellence. The Estimated Total Contract Value including VAT detailed below is illustrative and VAT will only be charged if applicable.

Classification

  • CPV09343000 — Radioactive materials
  • CPV33124000 — Diagnostics and radiodiagnostic devices and supplies
  • CPV33140000 — Medical consumables
  • CPV33151000 — Radiotherapy devices and supplies
  • CPV33151400 — Radiotherapy supplies
  • CPV33600000 — Pharmaceutical products
  • CPV33694000 — Diagnostic agents
  • CPV85145000 — Services provided by medical laboratories
  • CPV85149000 — Pharmacy services

Lots

  • Lot 1Value not stated

Documents and notices

Published notice details

Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.

Scope, procedure and submissions

Id
ST23-P026
Status
planning
Above Threshold
Yes
Main Procurement Category
services

Legal basis

Id
2023/54
Scheme
UKPGA

Communication

Future Notice Date
1 Oct 2025, 23:59

Lots and requirements

Entry 1
Id
1
Status
planning
Has Renewal
Yes

Contract period

Ends
31 May 2038, 23:59
Starts
1 Jun 2026, 00:00
Max Extent Date
31 May 2043, 23:59

Items and delivery

Item 1
Id
1
Related Lot
1

Delivery locations

Entry 1
Region
UKI
Country
GB
Country Name
United Kingdom

Additional Classifications

Entry 1
Id
85149000
Scheme
CPV
Description
Pharmacy services
Entry 2
Id
33151400
Scheme
CPV
Description
Radiotherapy supplies
Entry 3
Id
33151000
Scheme
CPV
Description
Radiotherapy devices and supplies
Entry 4
Id
33124000
Scheme
CPV
Description
Diagnostics and radiodiagnostic devices and supplies
Entry 5
Id
33694000
Scheme
CPV
Description
Diagnostic agents
Entry 6
Id
33600000
Scheme
CPV
Description
Pharmaceutical products
Entry 7
Id
33140000
Scheme
CPV
Description
Medical consumables
Entry 8
Id
85145000
Scheme
CPV
Description
Services provided by medical laboratories
Entry 9
Id
09343000
Scheme
CPV
Description
Radioactive materials

Planning and budget

Documents

Entry 1
Id
050413-2025
Format
text/html
Notice Type
UK2
Description
Preliminary market engagement notice on Find a Tender
Document Type
marketEngagementNotice
Published
21 Aug 2025, 10:13

Milestones

Entry 1
Id
engagement
Type
engagement
Status
scheduled
Due
1 Oct 2025, 23:59
Description
1 Introduction Guy’s and St Thomas’ NHS Foundation Trust (GSTT/the Trust) is pleased to announce an upcoming virtual market engagement event on Friday 19th September 2025 (11:30 – 12:30), in the form of a panel discussion with key stakeholders from GSTT. GSTT invites industry partners to participate in this engagement exercise to explore an exciting Managed Service Agreement (MSA) opportunity for the design, build and delivery of a Radiopharmacy Manufacturing Unit and Services for the Trust. This event aims to introduce the MSA opportunity, gather industry insights, and foster collaboration to shape the future of Radiopharmacy services at GSTT. 2 Objectives of the Market Engagement Event The panel discussion will: • Introduce the MSA opportunity and outline GSTT’s strategic vision for the new unit. • Test and refine the service model and financial framework to ensure alignment with supplier capabilities and market expectations. • Engage with industry stakeholders to gather insights and feedback on the procurement approach and specifications. • Foster collaboration and explore potential strategic partnerships with industry leaders. 3 Scope of the MSA Opportunity The MSA opportunity will encompass: • Design, build, and operation of a future-proofed state-of-the-art GMP-compliant Radiopharmaceutical Manufacturing Unit. • Aseptic manufacturing of diagnostic (SPECT and PET) and therapeutic radiopharmaceuticals for both routine use and clinical trials. • Production of investigational medicinal products (IMP) to support innovative clinical research. • Integration with existing GSTT pathways, ensuring high standards of patient safety and quality assurance. • Cell labelling services. This partnership will require operational excellence, regulatory compliance, and the ability to adapt to evolving market demands. It is anticipated the MSA contract will be awarded for a period of 12 years with an option to extend by a further 5 years. The contract value (exclusive of VAT) is estimated to be £42m for the first 12 years and £27m for the optional extension (total £69m) 4. Managed Service Agreement (MSA) A Managed Service Agreement (MSA) is a contract between an organisation (GSTT) and an external provider (the Supplier) to deliver and manage specific services or operations over an agreed period. Under an MSA, the supplier is responsible for end-to-end management, including staffing, equipment, maintenance, and compliance, ensuring that the service is delivered efficiently and consistently, in accordance with GSTT requirements. 5. Approach to procurement GSTT is planning to undertake a Competitive Flexible Procedure under the Procurement Act 2023 to select the right partner. To ensure transparency and gather industry insights, GSTT is hosting this virtual market engagement event to outline the project’s scope, expectations, and strategic direction. This will be followed by an opportunity for an individual meeting with GSTT to explore the opportunity in more detail. Please confirm your attendance by Wednesday 17th September 2025.

Buyer, suppliers and contacts

Organisation 1
Id
GB-PPON-PDZC-6438-DGPX
Name
Guy's and St Thomas' NHS Foundation Trust

Roles

buyer

Address

Region
UKI44
Country
GB
Locality
London
Postal Code
SE1 9RT
Country Name
United Kingdom
Street Address
Great Maze Pond

Details

Classifications

Entry 1
Id
publicAuthorityCentralGovernment
Scheme
UK_CA_TYPE
Description
Public authority - central government

Identifier

Id
PDZC-6438-DGPX
Scheme
GB-PPON

Contact

Name
Alizeh Ahmed

Recorded locations

  • Buyer location · London · UKI44 · SE1 9RT · United Kingdom
  • Delivery location · UKI · United Kingdom

Notice and amendment history

1 published notice version reviewed by ProcuraAxis.

1 VERSION
  1. ocds-h6vhtk-058bd9-2025-08-21T10:13:11+01:00Preliminary market engagement notice on Find a Tender ·